Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study of ASP015K: Single-Dose and Multiple-Dose Oral Administration in Healthy Nonelderly Men

NCT01225224 is registered in ClinicalTrials.gov with Astellas Pharma Inc as lead sponsor.

NCT NCT01225224
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01225224 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study of ASP015K: Single-Dose and Multiple-Dose Oral Administration in Healthy Nonelderly Men
Lead sponsor
Astellas Pharma Inc
Phase
Phase 1
Overall status
Completed
Start date
November 18, 2009
Completion date
March 10, 2010
Enrollment
72 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy volunteer, pharmacokinetics of asp015k